Defined Health`s Therapeutic Insight Conference to Fold into BIO-Europe Spring® and BioPharm America Partnering Conferences CARLSBAD, Calif. & ZURICH, Switzerland & FLORHAM PARK, N.J.–(Business Wire)– EBD Group and Defined Health today announced the formation of an alliance that will help biopharmaceutical firms gain the insights they need to create and execute successful strategy. Under this agreement, Defined Health will fold its highly regarded Therapeutic Insight conference into EBD Group`s BIO-Europe Spring® and BioPharm America partnering conferences. These events will now feature a “Defined Health Therapeutic Insight Track” that will bring together a diversity of industry thought-leaders and clinicians to explore transformative growth issues in leading therapeutic categories such as oncology, pain, CNS, cardiovascular and metabolic diseases, COPD and platforms such as orphan diseases, biosimilars and next-generation biologicals.

Since 2001, Therapeutic Insight has explored licensing and business development and disease area strategy informed by Defined Health`s 25 years of experience deep within and widely across the therapeutic area spectrum. The conference features panels that shed light on issues facing pharma and biotech companies including challenges to the blockbuster business model, the need for pharma companies to “focus down” to a limited number of therapeutic franchises, the push to externalize R&D and even potential deconstruction of the industry along core competency lines.

Carola Schropp, President of EBD Group, said, “We are excited to work with Defined Health, and welcome Therapeutic Insight into our conference program, which will greatly add to the vibrancy of our growing community of partnering events. Defined Health`s Therapeutic Insight is widely recognized as the event where key challenges confronting scientific, clinical and commercial success are examined and resolved.”

“The knowledge gleaned from Defined Health`s Therapeutic Insight program, in tandem with EBD Group`s sophisticated partnering capabilities, will give our conference delegates an unrivalled business development platform that supports better decisions and better deals.”

“The Defined Health team has always been very impressed with the quality and senior level attendance at EBD Group`s partnering conferences,” said Ed Saltzman, President of Defined Health. “We are excited at the prospect of joining with EBD Group to bring an added element of important content and context to attendees that will highlight key issues and drivers within their particular dealmaking space.”

About EBD Group

EBD Group is the leading partnering firm for the global life science industry. Since 1993, biotech, pharma and medical device companies have leveraged EBD Group`s partnering conferences, technology and services to identify business opportunities and develop strategic relationships essential to their success.

EBD Group`s conferences are run with the support of leading corporations and international trade associations, and include:

• BIO-Europe and BIO-Europe Spring, Europe`s largest life science partnering conferences, supported by the Biotechnology Industry Organization (BIO)
• BioPharm America, the fastest growing partnering event in North America
• EuroMedtech, EBD Group`s new partnering event for the innovative medical technology industry
• BioEquity Europe, the investor conference co-organized with BioCentury Publications and BIO
• ChinaBio Partnering Forum, the first dedicated biotech/pharma partnering conference in China, co-produced with ChinaBio LLC
• Biotech Showcase, a unique forum in San Francisco for presenting to investors and business development executives, co-produced with Demy-Colton Life Science Advisors

EBD Group`s sophisticated web-based partnering service, partneringONE, is used as the partnering engine at numerous third-party events around the world.

Outside of the conference format, EBD Group`s consultants provide hands-on assistance for firms seeking to in- or out-license products and technologies.

EBD Group has offices in the USA and Europe.

For more information visit www.ebdgroup.com

About Defined Health

Defined Health is a leading strategic business development consulting service with a core strength in evaluating pipeline compounds (internal or external) from a scientific, clinical and commercial standpoint, and in assisting clients in developing therapeutic area growth strategies, including identification of in-licensing and M&A opportunities. Defined Health adds value by providing an objective, informed, external view - helping to answer the important questions of value, such as:

• What is the potential commercial value of this opportunity?
• Does the science make sense?
• What will be the standard of care in the next decade?
• How will this potential compound fit in?
• In which patient subsets will it be used?
• What drugs will it supplant, and why?
• Who will prescribe it?
• Who will pay for it and what does it need to do to be paid for?
• What do we need to show to prove relevance, and how much do we need to invest in development to the next stage?
• Should we acquire this asset? If yes, for how much?
• Should we partner this asset? Who is on the short list of the most suitable partners?
• What does the competitive landscape look like, what will it take for us to compete successfully?

Defined Health has 25 years of experience resulting in deep knowledge of the therapeutic space, competitive landscape, current and evolving standards of care, treatment and referral practices, pricing and reimbursement dynamics, biomarkers, opportunity for personalized medicine approaches and what novel approaches in the pipeline look most promising, for example. Defined Health`s breadth of experience includes extensive work in Oncology, Cardiovascular Disease, Metabolics, CNS disorders (both neurological and psychological), and a host of other areas, including Ophthalmology, Anti-virals, Antibiotics, Inflammatory Diseases, Women’s Health, Immunology and Auto-Immune Diseases, Dermatology, Rheumatology, Musculoskeletal Disorders, Hematological Disorders, Orphan Diseases, etc.

Over the years, Defined Health has helped to assess the value of many of the industry`s headline partnering and M&A deals.

For more information please visit www.definedhealth.com.

EBD Group

Constantine Theodoropulos, +1-617-292-7319
ctheodoropulos@ebdgroup.com

Defined Health

Ginny Llobell, +1-973-292-5001
gllobell@definedhealth.com